Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 6/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 6/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrahydrofuran SCHEMBL10619778 | 0.98 | TP53 (0.68) | TP53ALDH1A1CHRM2CHRM4CHRM5 | |
| Oxirane SCHEMBL826683 | 0.86 | — | — | |
| Ethane SCHEMBL3670045 | 0.78 | — | — | |
| Water SCHEMBL14353431 | 0.78 | — | — | |
| SCHEMBL27484100 | 0.78 | — | — | |
| Methane SCHEMBL25269682 | 0.78 | — | — | |
| Ammonia Solution, Strong SCHEMBL1291269 | 0.78 | — | — | |
| Hydrogen Sulfide SCHEMBL15020519 | 0.78 | — | — | |
| SCHEMBL28163366 | 0.78 | — | — | |
| Water SCHEMBL28149279 | 0.78 | TP53 (0.94) | TP53ALDH1A1USP2POLBPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118103345-A | Method for producing compound comprising isomerization step of alpha, beta-unsaturated ketone | 花王株式会社 | 2024-05-28 | — | — | CN | disclosed |
| EP-2487150-B1 | PROCESS FOR PRODUCING A LACTONE | KAO CORP (JP) | 2016-12-28 | — | — | EP | disclosed |
| EP-2266943-B1 | METHOD FOR PRODUCING OF 2-ALKYL-2-CYCLOALKEN-1-ONE | KAO CORP (JP) | 2016-11-16 | — | — | EP | disclosed |
| US-8394994-B2 | Method for producing of 2-alkyl-2-cycloalken-1-one | KAO CORPORATION (JP) | 2013-03-12 | — | — | US | disclosed |
| EP-2487150-A1 | PROCESS FOR PRODUCING 2-ALKYLCYCLOALKANONE | Kao Corporation (JP) | 2012-08-15 | — | — | EP | disclosed |
| US-20110034722-A1 | METHOD FOR PRODUCING OF 2-ALKYL-2-CYCLOALKEN-1-ONE | KAO CORPORATION (JP) | 2011-02-10 | — | — | US | disclosed |
| EP-2266943-A1 | METHOD FOR PRODUCING OF 2-ALKYL-2-CYCLOALKEN-1-ONE | Kao Corporation (JP) | 2010-12-29 | — | — | EP | disclosed |
| EP-0122935-A1 | METHOD FOR PREPARING ORGANIC HYPONITRITES | BOARD OF CONTROL OF MICHIGAN TECHNOLOGICAL UNIVERSITY (US) | 1984-10-31 | — | — | EP | disclosed |
| WO-1984001770-A1 | METHOD FOR PREPARING ORGANIC HYPONITRITES | UNIV MICHIGAN TECH (US) | 1984-05-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110034722-A1 | METHOD FOR PRODUCING OF 2-ALKYL-2-CYCLOALKEN-1-ONE | PAOX, CYP1A1, ADH1A | TP53 677/4885ALDH1A1 191/4885CHRM2 741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.